PARICALCITOL

Product NDC: 69387-104
11-digit product format: 693870104
Labeler code: 69387
Product ID: 69387-104_f529b1d8-ba53-42f1-9cc4-5767f63a043d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: PARICALCITOL
Dosage form: CAPSULE
Route: ORAL
Labeler: Banner Life Sciences LLC.
Application: ANDA202539
Marketing category: ANDA
Marketing start: 2015-10-01
Marketing end: 0000-00-00
Substance: PARICALCITOL
Active strength: 2 mg/1
Pharmacologic classes: Cholecalciferol [CS],Vitamin D3 Analog [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	69387-104		I	Inactivated by FDA		2026-08-10
excluded package	package	69387-104	69387-104-30	I	Inactivated by FDA		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69387-104-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69387-104-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69387-104-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69387-104-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69387-104-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69387-104-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69387-104-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69387-104-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69387-104-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69387-104-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69387-104-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69387-104-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69387-104-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69387-104-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69387-104-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	69387-104-30	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	69387-104-30	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	69387-104-30	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	69387-104-30	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	69387-104-30	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	69387-104-30	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	69387-104-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A202539-001	PARICALCITOL	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27
A202539-002	PARICALCITOL	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27
A202539-003	PARICALCITOL	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A202539-001	AB
A202539-002	AB
A202539-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202539-002	PARICALCITOL	2MCG	CAPSULE / ORAL	AB	2014-03-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202539-003	PARICALCITOL	4MCG	CAPSULE / ORAL	AB	2014-03-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202539-001	PARICALCITOL	1MCG	CAPSULE / ORAL	AB	2014-03-27	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A202539-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202539-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202539-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202539-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202539-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202539-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202539-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202539-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202539-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202539-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202539-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202539-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202539-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202539-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202539-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202539-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202539-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202539-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202539-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202539-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202539-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202539-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202539-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202539-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202539-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202539-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202539-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202539-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202539-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202539-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202539-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202539-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202539-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202539-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202539-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202539-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202539-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202539-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202539-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202539-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
d92c0b9e-f894-bf80-45eb-73308b7f7f62	Product name	8	20190124
7792dadb-52b6-46b6-8fdf-80b1171065b5	Product name	1	20180810
3c05259b-d0ee-c435-cb1a-db5d01cf3e37	Product name	5	20161206
35d6155d-80a2-4122-bd18-18decc40ac12	Product name	2	20150902

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
69387-104-30	2020-01-31	C162847	48780-1	9d75b9d0-7954-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use paricalcitol capsules safely and effectively. See full prescribing information for paricalcitol capsules. PARICALCITOL Capsules Initial U.S. Approval: 1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
69387-104-30	PARICALCITOL	30 in 1 BOTTLE, PLASTIC	CAPSULE	30		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69387-104-30	EA - Each	69387-104	bdd1d988-76cc-4758-9910-0966c85b28f3	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PARICALCITOL	ACTIVE INGREDIENT	6702D36OG5	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
PARICALCITOL	ACTIVE MOIETY	6702D36OG5	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69387-104	PARICALCITOL CAPSULE [BANNER LIFE SCIENCES LLC.]	2	Legacy NDC, 1 package rows	20151001_108e4cb1-6e43-44fd-b228-cd23203fccda.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Paricalcitol	PARICALCITOL	Bryant Ranch Prepack	664253fb-d99d-4af6-971b-95c0087406d9	2026-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202539 application number: ANDA202539
Paricalcitol	PARICALCITOL	Bryant Ranch Prepack	22a0d467-9881-458f-8b1c-1186feb96ee4	2024-08-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202539 application number: ANDA202539
Paricalcitol	PARICALCITOL	Bryant Ranch Prepack	52ca3d88-e85d-44a9-8aa7-eb25a8a73f6f	2024-06-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202539 application number: ANDA202539
Paricalcitol	PARICALCITOL	Bryant Ranch Prepack	d62d977a-bbfc-454a-a4a9-017a9f525574	2024-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202539 application number: ANDA202539
Paricalcitol	PARICALCITOL	Bionpharma Inc.	755476e5-62a2-4f01-92a3-307e192ad42c	2023-12-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202539 application number: ANDA202539

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6702D36OG5	PARICALCITOL	131918-61-1	PARICALCITOL

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
69387-104-30	69387010430	30 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
PARICALCITOL	Banner Life Sciences LLC. \| Banner Pharmacaps Inc.	2015-09-08	HUMAN PRESCRIPTION DRUG LABEL	2